Repro LOs Flashcards
1. Document clinical findings of the breast using appropriate anatomical landmarks (eg, upper outer quadrant) and/or face of a clock (eg, 3 o’clock) with the distance from the nipple in centimeters (p 406)
- 4 Quadrants
- Fifth Area: Axillary Tail of Breast Tissue (“tail of Spence”
- “Breast pendulous w/ diffuse fibrocystic changes. Single, firm 1x1cm mass, mobile and non-tender noted in right breast upper outer quadrants at 11 o’clock, ~2cm from nipple”
2. Identify and discriminate the clinical significance, presenting signs, differential diagnosis, and further evaluation including laboratory and/or diagnostic imaging tests for the following common and concerning breast symptoms:
-
a. Breast lump or mass (p 430)
- Breast Cyst
-
Age: 30-50
- Regress post-menopause
- (expect w/estrogen rx)
- Regress post-menopause
- Number: 1 or more
- Shape: Round
- Consisitency: Soft to Firm; elastic
- Delimitation: Well-Delinated
- Mobility: Mobile
- Tenderness: often Tender
- Retraction: Absent
2. Identify and discriminate the clinical significance, presenting signs, differential diagnosis, and further evaluation including laboratory and/or diagnostic imaging tests for the following common and concerning breast symptoms:
-
a. Breast lump or mass (p 430)
- Fibroadenoma
-
Age: 15-25
- Usually puberty/young adult
- Up to age 55
- Number: 1 or more
- Shape: Round, disc-like, lobular
- Consisitency: May be soft, usually firm
- Delimitation: Well-Delinated
- Mobility: Very Mobile
- Tenderness: Usually Non-Tender
- Retraction: Absent
2. Identify and discriminate the clinical significance, presenting signs, differential diagnosis, and further evaluation including laboratory and/or diagnostic imaging tests for the following common and concerning breast symptoms:
-
a. Breast lump or mass (p 430)
- Breast Cancer
-
Age: 30-90
- More common >50
-
Number:Usualy single
- May have other nodules
- Shape: Irregular or Stellate
- Consisitency: Firm or Hard
- Delimitation: Not clearly Delineated
- Mobility: May be fixed to skin/underlying tissues
- Tenderness: Usually Non-tender
- Retraction: May be Present
2. Identify and discriminate the clinical significance, presenting signs, differential diagnosis, and further evaluation including laboratory and/or diagnostic imaging tests for the following common and concerning breast symptoms:
-
Breast Cancer
- Retraction Signs (p 431)
Advancing Breast CA causes:
- Fibrosis (Scar Tissue)
- Tissue shortens =’s
- dimpling
- changes in contour
- retration/nipple deviation
- Tissue shortens =’s
Other causes of retraction:
- Fat Necrosis
- Mammary Duct Ectasia
2. Identify and discriminate the clinical significance, presenting signs, differential diagnosis, and further evaluation including laboratory and/or diagnostic imaging tests for the following common and concerning breast symptoms:
-
Breast Cancer
- Abnormal Contours (p 431)
Look for:
- Variation in normal convexity of each breast
- Compare both breasts
Use Special Positioning
2. Identify and discriminate the clinical significance, presenting signs, differential diagnosis, and further evaluation including laboratory and/or diagnostic imaging tests for the following common and concerning breast symptoms:
-
Breast Cancer
- Skin Dimpling (p 431)
Look for when:
- Arm is at Rest
- Special Positioning
- Moving & Compressing Breast
2. Identify and discriminate the clinical significance, presenting signs, differential diagnosis, and further evaluation including laboratory and/or diagnostic imaging tests for the following common and concerning breast symptoms:
-
Breast Cancer
- Nipple Retraction & Deviation
Retracted Nipple:
- Pulled inward
- Flattened
- May be:
- Broadened
- Feel Thickened
If Asymmetric Involvement:
- May deviate or point in different direction
- Typically toward the CA
2. Identify and discriminate the clinical significance, presenting signs, differential diagnosis, and further evaluation including laboratory and/or diagnostic imaging tests for the following common and concerning breast symptoms:
-
Breast Cancer
- Edema of the Skin (p 431)
Produced by lymphatic blockage
Appears as:
- Thickened skin
- Enlarged Pores
- “peau d’orange sign”
(Often) first seen in lower breast or areolar region
2. Identify and discriminate the clinical significance, presenting signs, differential diagnosis, and further evaluation including laboratory and/or diagnostic imaging tests for the following common and concerning breast symptoms:
-
Breast Cancer
- Paget’s Disease of the Nipple (p431)
Uncommon form of Breast CA
Starts:
- Scaly
- Eczema-like lesion
- May: Weep, crust, erode
- May have: Breast Mass
Suspect if: Dermatitis of nipple or areola
Can present with: Invasive Breast CA, or DCIS
2. Identify and discriminate the clinical significance, presenting signs, differential diagnosis, and further evaluation including laboratory and/or diagnostic imaging tests for the following common and concerning breast symptoms:
- b. Breast Pain or Discomfort (p408)
Ask about breasts during hx or during PE
Ask: Any discomfort, pain, or lumps in breasts?
~50% of women have palpable lumps or nodularity; pre-menstrual enlargement & tenderness are common
Wide ranges of changes in Breast Tissue & Sensation:
- Cyclic Swelling & Nodularity
- Distinct Lumps/Masses
2. Identify and discriminate the clinical significance, presenting signs, differential diagnosis, and further evaluation including laboratory and/or diagnostic imaging tests for the following common and concerning breast symptoms:
-
c. Nipple Discharge
-
i. Galactorrhea (p 409)
- Pt. 1
-
i. Galactorrhea (p 409)
- Ask about: Discharge from Nipples
- When does it occur?
- Compression? Spontaneous?
- When does it occur?
Physiologic Hypersecretion seen in:
- Pregnancy
- Lactation
- Chest Wall Stimulation
- Sleep
- Stress
2. Identify and discriminate the clinical significance, presenting signs, differential diagnosis, and further evaluation including laboratory and/or diagnostic imaging tests for the following common and concerning breast symptoms:
-
c. Nipple Discharge
-
i. Galactorrhea (p 409)
- Pt. 2
-
i. Galactorrhea (p 409)
- If spontaneous discharge:
- Color?
- Milky? Brown? Green? Blood?!
- Consistency?
- Quantitiy?
- Color?
- Unilateral or Bilateral Discharge?
2. Identify and discriminate the clinical significance, presenting signs, differential diagnosis, and further evaluation including laboratory and/or diagnostic imaging tests for the following common and concerning breast symptoms:
-
c. Nipple Discharge
-
i. Galactorrhea (p 409)
- Pt. 3
-
i. Galactorrhea (p 409)
Glactorrhea:
- Inappropriate discharge of milk-containing fluid
- Abnormal if:
- occurs 6 or more months post-childbirth or cessation of breast feeding
3.Analyze and assess female patients’ risk of breast cancer by gaining a general understanding of each of the following:
a. Lifetime risk of developing invasive breast cancer (p 410)
- Most common cause of CA in women Worldwide!*
- >10% of CA in women*
- 2nd leading cause of CA death in women*
In US:
- 12% or 1 in 8 lifetime risk
95% of new cases occur in women 40+
Probability increases by decade
3.Analyze and assess female patients’ risk of breast cancer by gaining a general understanding of each of the following:
b. Factors that increase relative risk of breast cancer (p 411-412)
***MOST IMPORTANT RISK FACTOR!!***
Most Important Risk Factor
AGE
3.Analyze and assess female patients’ risk of breast cancer by gaining a general understanding of each of the following:
b. Factors that increase relative risk of breast cancer (p 411-412)
*Modifiable Risk Factors*
Modifiable Risk Factors
- Post-menopausal obesity
- Use of HRT
- Alcohol use
- Physcial Inactivity
- Breast-Feeding choice
- Contraceptive choice
- Radiation Exposure
3.Analyze and assess female patients’ risk of breast cancer by gaining a general understanding of each of the following:
b. Factors that increase relative risk of breast cancer (p 411-412)
*Non-Modifiable Risk Factors*
Non-Modifiable Risk Factors:
- Family History
- Breast Tissue Density
- Proliferative Lesions w/ Atypia on Breast Bx
- Duration of Unopposed Estrogen Exposure (earlly menarche/late menopause)
- Age of First Full-Term Pregnancy
3.Analyze and assess female patients’ risk of breast cancer by gaining a general understanding of each of the following:
b. Factors that increase relative risk of breast cancer (p 411-412)
*Nonetheless….. Basically Anyone can get Breast CA***
“Over 50% of Women w/ Breast CA have no Familial or Reproductive Risk Factors”….
3.Analyze and assess female patients’ risk of breast cancer by gaining a general understanding of each of the following:
b. Factors that increase relative risk of breast cancer (p 411-412)
Male Breast Cancer
- Male Breast CA:
- 1% of all Breast CA
- Peaks ~71yo
- Risk Factors:
- BRCA2 Mutations
- Obesity
- Family Hx of M/F Breast CA
- Testicular D/Os
- Work Exposures!
3.Analyze and assess female patients’ risk of breast cancer by gaining a general understanding of each of the following:
C. Breast cancer risk assessment tools (eg, Gail model; p 412-413)
- Risk Assessment Tools
-
Gail & Claus:
- Estimate Absolute Lifetime Risk of Breast CA
- Most commonly used
- Assess based on large population data
- DO NOT: Predict dz in Indivdual
-
BRCAPRO Model:
- Predicts Risk of BRCA 1 or BRCA2
NO Single Model Addresses ALL known RFs or Includes all of Genetic Details of Personal/Family Hx
3.Analyze and assess female patients’ risk of breast cancer by gaining a general understanding of each of the following:
C. Breast cancer risk assessment tools (eg, Gail model; p 412-413)
- Gail Model -
- Gail Model:
- 5-year Lifetime Estimates of
- Risk for Invasive Breast CA
- Incorporates:
- Age
- Race
- 1st Degree Relatives w/ BreastCA
- Previous Breast Bx
- Hyperplasia presence
- First Menarche
- First Delivery
- Best For:
- Ages 50+
- w/ no Family Hx, or 1 first degree relative
- Annual Screening Mammograms
- DONT Use for:
- Hx of Breast CA or Radiation Exposure
- <35yo
- DOES NOT:
- Determine Risk for Non-Invasive Breast CA
- No Paternal Hx, or 2nd Degree Relatives
- 5-year Lifetime Estimates of
- Includes Breast Density….but is getting more Difficult to Use!
3.Analyze and assess female patients’ risk of breast cancer by gaining a general understanding of each of the following:
C. Breast cancer risk assessment tools (eg, Gail model; p 412-413)
- Claus Model -
- Claus Model:
- Assess risk for High-Risk Women
- Incorporates:
- Family Hx
- M/F 1st & 2nd degree relatives
- Includes Age @ Onset
- Women’s Current Age
- Family Hx
- Best for:
- Individuals w/no more than
- 2 1st/2nd degree relatives w/Breast CA
- Individuals w/no more than
- Expanded Version:
- Family Members w/ Ovarian CA
- DOES NOT Include:
- Person
- Lifestyle
- Reproductive Risk Factors
Downside: Has been discrepancies btwn published tables & computerized versions
3.Analyze and assess female patients’ risk of breast cancer by gaining a general understanding of each of the following:
C. Breast cancer risk assessment tools (eg, Gail model; p 412-413)
- BRCAPRO Model -
- BRCAPRO Model:
- High Risk Women
- Assess risk of:
- BRCA 1 & BRCA 2 mutations
- Incorporates:
- Published BRCA 1 & 2 mutation freq.
- Cancer penetration in affected carriers
- Age of Onset in 1/2nd degree M/F relatives
- DOES NOT Include:
- Non-Hereditary RFs
3.Analyze and assess female patients’ risk of breast cancer by gaining a general understanding of each of the following:
D. Family history – BRCA1 and BRCA2 mutations (p 413-414)
- Ask about Family Hx starting ~age 20
- Pattern of Breast/Ovarian CA = suspicious
- Autosomal Dominant Genetic Mutations
- Look for:
- family hx
- Age <50yo @ dx
- Breast CA in 2+ ppl of same lineage (paternal or maternal)
- Multiple primary or ovarian tumors in 1 person
- Breast CA in male relative
- Ashkenazi Jewish Ancestry
- Family Member w/ predisposing gene
- family hx
3.Analyze and assess female patients’ risk of breast cancer by gaining a general understanding of each of the following:
D. Family history – BRCA1 and BRCA2 mutations (p 413-414)
- BRCA 1 & 2 gene mutations =
- 1/2 of Familial Breast CAs
- & Increased Risk for Ovarian CA
- Mutations in <1% of population
- but 5% of Breast CA!!
- BRCA 1 = risk of Breast CA = 57%
- BRCA 2 = risk of Breast CA = 49 %
- (by age of 70)
3.Analyze and assess female patients’ risk of breast cancer by gaining a general understanding of each of the following:
D. Family history – BRCA1 and BRCA2 mutations (p 413-414)
If suspect Familial History:
- BRCAPRO Calculator
- Coduct Genetic Testing
- Consider MRI screen (in addition to Mammogram)
- Make appropriate Specialty Referrals
3.Analyze and assess female patients’ risk of breast cancer by gaining a general understanding of each of the following:
E. Screening mammography recommendations including frequency (p 415)
- Step 1: Screen all women for Risk Factors!
- (via tables & models)
- Ask about Ovarian CA
-
Controversy amoung groups on when to start screening….
- Risk vs. Benefit Reviews
3.Analyze and assess female patients’ risk of breast cancer by gaining a general understanding of each of the following:
E. Screening mammography recommendations including frequency (p 415)
*Ages 40 - 50*
- Mammography (Women ages 40-50)
- Controversial
- Lower Sensitivity & Specificity
- related to: Heterogenous Estrogen pre-menopausal exposure
- High ### of False Positives (~10%)
- Resulting in unneccasry invasive procedures
3.Analyze and assess female patients’ risk of breast cancer by gaining a general understanding of each of the following:
E. Screening mammography recommendations including frequency (p 415)
* Ages 40-50 *
- Mammography (Women ages 40-50)
-
USPSTF Recommends:
-
Under age 50:
- “Individual Decision Making” versus Routine Biennial Screening
- Take patient context into account
-
Under age 50:
- American College of Physicians agree
- v. AMA & ACS Recommend:
- Annual Mammorgraphy beginning at Age 40!
-
USPSTF Recommends:
3.Analyze and assess female patients’ risk of breast cancer by gaining a general understanding of each of the following:
E. Screening mammography recommendations including frequency (p 415)
* Ages 50-74 *
- Mammography (Women ages 50-74 years)
-
Performs best in this age group!
- Sensitive (77-95%)
- Specific (94-97%)
-
USPSTF Recommends (2009):
- Ages 50-74
- Biennial Screening for women
- Reduces harms of mammography screening by 1/2
- Preserves 80% of benefits of annual screening
- Averts 40% of False +’s
- Similar diagnostic & 10yr survival rates as annual
- Biennial Screening for women
- Ages 50-74
-
Performs best in this age group!
- v. AMA & ACS Recommend:
- Annual Mammorgraphy
-
WHO recommends:
- every 1-2 years
3.Analyze and assess female patients’ risk of breast cancer by gaining a general understanding of each of the following:
E. Screening mammography recommendations including frequency (p 415)
“Digital Mammography performs better in Younger Women & Women w/ Higher Breast Density”
3.Analyze and assess female patients’ risk of breast cancer by gaining a general understanding of each of the following:
E. Screening mammography recommendations including frequency (p 415)
*Ages 75+*
-
Mammography in Women ages 75+
-
USPSTF, ACS, AGS:
-
Support “Individualized Decisions” re: continued screening
- Depending on co-exisiting conditions/5-yr survivial
-
Support “Individualized Decisions” re: continued screening
-
USPSTF, ACS, AGS:
-
USPSTF concludes:
- 3 Factors that alter benefits of screening for this age group:
- Benefits occur several years later
- CA more likely to be Estrogen-Receptor + =’s easily treatable
- More likely to die of other conditions
- No women aged 75+ have been included in trials
- “Data insuffient to make firm recommendation”
- 3 Factors that alter benefits of screening for this age group:
3.Analyze and assess female patients’ risk of breast cancer by gaining a general understanding of each of the following:
F. Clinical breast examination including frequency (CBE; p 416)
- 2009 - USPSTF
- “CBE is Insufficient for Establishing Balance of Benefit v. Harms”
- WHO agrees
- “CBE is Insufficient for Establishing Balance of Benefit v. Harms”
- vs. ACS recommends:
- CBE q 3 years for 20-39yo
- Annual (before mammo) @ 40+yo
- “CBE = education for patient, even if time consuming (10+minutes)
-
ACOG = Recommends CBE
- Wants Standardization
*
- Wants Standardization
3.Analyze and assess female patients’ risk of breast cancer by gaining a general understanding of each of the following:
F. Clinical breast examination including frequency (CBE; p 416)
- Sensitivity of CBE: 40%
- Specificity of CBE: 88-99%
- Very influenced by Technique of Examiner!*
3.Analyze and assess female patients’ risk of breast cancer by gaining a general understanding of each of the following:
G. Breast self-examination including frequency (BSE; p 416, 426-427)
- USPSTF (2009)
- Recommended teaching AGAINST teaching BSE
- Evidence:
- Does NOT reduce Mortality
- May lead to more bengign biopsies (bx)
- ACS
-
Advocates BSEs w/ Mammography & CBE
- Promote Health Awareness
- Advises Clinicians to Teach & Review Technique
-
Advocates BSEs w/ Mammography & CBE
- Some studies:
- “Women performing BSE = more likely to pursue mammography”
- May benefit high risk women
3.Analyze and assess female patients’ risk of breast cancer by gaining a general understanding of each of the following:
G. Breast self-examination including frequency (BSE; p 416, 426-427)
- Sensitivity: 12-41%
- Some say: Duration & Frequency = inadequate
3.Analyze and assess female patients’ risk of breast cancer by gaining a general understanding of each of the following:
G. Breast self-examination including frequency (BSE; p 416, 426-427)
- Monthly BSE 5 to 7 days after menses onset
- can be taught to women starting at age 20
3.Analyze and assess female patients’ risk of breast cancer by gaining a general understanding of each of the following:
G. Breast self-examination including frequency (BSE; p 416, 426-427)
**Instructions for BSE**
- Inexpensive
- High proportion of breast masses are detected by individual examining own breasts
- Promotes Stronger Health Awareness
- More active self-care
- Use w/CBE & Mammographies
- Best timed 5-7 days after Menses
3.Analyze and assess female patients’ risk of breast cancer by gaining a general understanding of each of the following:
G. Breast self-examination including frequency (BSE; p 416, 426-427)
**Instructions for BSE - Lying Supine**
- See page 427 of Bates
-
Lying Supine
- Pillow & Arm behind head of breast you’re examining
- Use finger pads
- Press w/ variations of pressure
- Press in Strip, Circle, or Wedge pattern (cover all tissue)
- Don’t forget the axilla region
- Do both breasts
- Contact Clinician if any abnormalities
3.Analyze and assess female patients’ risk of breast cancer by gaining a general understanding of each of the following:
G. Breast self-examination including frequency (BSE; p 416, 426-427)
**Instructions for BSE - Standing**
- See page 427 of Bates
-
Standing:
-
Hands press firmly on hips
- Inspect
- Examine each underarm while sitting up or standing & arm slightly raised
-
Hands press firmly on hips